- Article
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders
- Luca Ielasi,
- Francesco Tovoli,
- Matteo Tonnini,
- Raffaella Tortora,
- Giulia Magini,
- Rodolfo Sacco,
- Tiziana Pressiani,
- Franco Trevisani,
- Vito Sansone and
- Giovanni Marasco
- + 2 authors
Case–control observational studies suggested that aspirin might prevent hepatocellular carcinoma (HCC) in high-risk patients, even if randomized clinical trials are lacking. Information regarding aspirin in subjects who already developed HCC, e...

